Cross-flow membrane plasmapheresis technique for continuous ex vivo plasma sampling.
A technique is described for plasma sampling by continuous membrane plasmapheresis performed on blood flowing through an extracorporeal arteriovenous shunt. The plasmapheresis sampler in the shunt employs replaceable commercial planar membranes 2.5 cm in diameter. Validation tests were conducted for 0.6-micron pore diameter microporous membranes with several low-molecular-weight, nonmetabolized solutes that either rapidly equilibrate between plasma and formed elements or remain extracellular. Ex vivo tests were performed for bolus intravenous administration to rabbits. The technique yielded values for time-averaged plasma concentrations comparable to those obtained with serial blood and continuous blood withdrawal methods. The new technique should be particularly advantageous when the distribution of the solute of interest between plasma and formed elements of the blood undergoes significant changes during the sampling interval as a result of binding, exchange, or metabolism in the formed element phase.
Bungay
P M
PM
Biomedical Engineering and Instrumentation Program, National Institutes of Health, Bethesda, Maryland 20892-5766.
Fenstermacher
J D
JD
Krindel
P
P
Dedrick
R L
RL
Patlak
C S
CS
D000818:Animals; D001800:Blood Specimen Collection / Q000379:methods*; D002087:Butyrates / Q000493:pharmacokinetics; D003515:Cycloleucine / Q000493:pharmacokinetics; D006852:Hydrochlorothiazide / Q000493:pharmacokinetics; D058610:Isobutyrates; D008954:Models, Biological; D010956:Plasmapheresis / Q000295:instrumentation / Q000379:methods*; D011817:Rabbits; D013395:Sucrose / Q000493:pharmacokinetics; D014508:Urea / Q000493:pharmacokinetics
D002087:Butyrates; D058610:Isobutyrates; D006852:Hydrochlorothiazide; D003515:Cycloleucine; D013395:Sucrose; C020380:isobutyric acid; D014508:Urea